Clinical Trial Results
In this section you will find clinical trial information related to new and ongoing trials for which Bristol-Myers Squibb has disclosure responsibility. For more details, read our disclosure commitment
In compliance with the FDA Amendment Act of 2007, Bristol Myers Squibb has included adverse event (AE) and serious adverse event (SAE) information when disclosing clinical trial results from marketed products on the www.ClinicalTrials.gov website. The AE/SAE information contained on www.ClinicalTrials.gov represents data collected during the conduct of individual clinical trials. This information may not be indicative of the final aggregation of information included in the approved drug product label; therefore differences may exist between the data disclosed on www.ClinicalTrials.gov and the approved drug product label. The purpose of posting trial results is for disclosure and is not intended for aggregated analysis for signal detection purposes.
Select a therapeutic area: